Page last updated: 2024-08-24

2,2'-dithiodiethanesulfonic acid and amifostine anhydrous

2,2'-dithiodiethanesulfonic acid has been researched along with amifostine anhydrous in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, S; Haridas, K; Hausheer, FH; Kanter, P; Martinez, N; Murali, D; Petluru, P; Reddy, D; Rustum, YM; Saxe, JD; Seetharamulu, P; Yao, S; Zhao, M; Zukowski, A1
Boven, E; Erkelens, CA; Hausheer, FH; Hulscher, TM; Pinedo, HM; van der Vijgh, WJ; Verschraagen, M1
Galanski, M; Jakupec, MA; Keppler, BK1

Reviews

2 review(s) available for 2,2'-dithiodiethanesulfonic acid and amifostine anhydrous

ArticleYear
Modulation of platinum-induced toxicities and therapeutic index: mechanistic insights and first- and second-generation protecting agents.
    Seminars in oncology, 1998, Volume: 25, Issue:5

    Topics: Amifostine; Animals; Antineoplastic Agents; Cisplatin; Drug Interactions; Humans; Kidney Diseases; Mesna; Platinum Compounds; Protective Agents; Sulfhydryl Compounds

1998
The effect of cytoprotective agents in platinum anticancer therapy.
    Metal ions in biological systems, 2004, Volume: 42

    Topics: Amifostine; Antineoplastic Agents; Cell Survival; Glutathione; Humans; Mesna; Neoplasms; Platinum Compounds; Protective Agents; Thioctic Acid; Vitamin E

2004

Other Studies

1 other study(ies) available for 2,2'-dithiodiethanesulfonic acid and amifostine anhydrous

ArticleYear
BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts.
    European journal of cancer (Oxford, England : 1990), 2002, Volume: 38, Issue:8

    Topics: Amifostine; Animals; Antineoplastic Agents; Carboplatin; Cell Division; Cisplatin; Drug Interactions; Female; Humans; Lethal Dose 50; Mesna; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Protective Agents; Radiation-Protective Agents; Transplantation, Heterologous; Weight Loss

2002